Don Rule

Don Rule

Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products, and integrating Instant Messaging with Voice Over IP networks. Don founded the BioIT Alliance from within Microsoft to accelerate collaboration in translational research.

Read recent posts by this author below »

The Role of Clinical Pharmacogenomics in Managing Patient Expectations

By the end of 2018, more than 26 million consumers had undergone direct-to-consumer (DTC) genetic testing. These genetic tests promise to identify medically relevant genetic variants, identify a consumer’s genetic

3 Ways Pharmacogenomics is Securing its Place as a Standard of Care

A growing body of evidence has linked pharmacogenomic (PGx) testing to better patient outcomes, lower healthcare costs, reduced hospital readmission rates, and prevented adverse drug reactions. Change often comes to

Finding an Answer in Pharmacogenomics: One Patient’s Journey with PGx Testing

PGx testing has the ability to make a difference in the lives of patients. Here’s one patient story that demonstrates how PGx testing brought her peace of mind.

What New CPIC Guidelines Mean for Pharmacogenetics Implementation

Pharmacogenomics (PGx) has the power to revolutionize health care, save lives, reduce side effects, improve care outcomes, and save money. Illnesses like depression, which have high relapse rates and even higher

PGx Testing: Why Success Requires More Than Just Launching a Program

Pharmacogenomic (PGx) testing allows healthcare providers to make more informed, evidence-based decisions for their patients. To take advantage of this new clinical tool, we’ve recently seen several large